Actively Recruiting

Phase 4
Age: 18Years - 75Years
MALE
NCT06378645

Effect of Propofol vs. Sevoflurane on Erections During Narcosis In Transurethral Surgery

Led by Etienne Xavier Keller · Updated on 2024-04-22

200

Participants Needed

1

Research Sites

147 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Penile erection is an unwanted event in transurethral (through the urethra) surgeries, which may be associated with adverse outcomes such as impaired access, prolonged operation time, the need to abort the operation, or the necessity for ancillary measures to achieve penile flaccidity, such as the injection of certain medications directly into the penis. To reduce greenhouse gas emissions, the primary use of propofol instead of gaseous agents is being recommended for general anesthesia. Whether propofol may be associated with an increased or decreased rate of unwanted intraoperative penile erection compared to other anesthetic agents is not known. More generally, there are no high-quality studies available to evaluate the impact of the type of general anesthesia on the risk of unwanted penile erections during surgery. This study aims to determine whether general anesthesia with propofol is more likely to cause intraoperative erections compared to sevoflurane during transurethral operations.

CONDITIONS

Official Title

Effect of Propofol vs. Sevoflurane on Erections During Narcosis In Transurethral Surgery

Who Can Participate

Age: 18Years - 75Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Planned transurethral operation in the department of urology
  • Preoperative IIEF-5 Score of 12 or higher
  • Planned surgery time of at least 15 minutes
Not Eligible

You will not qualify if you...

  • Inability to follow study procedures due to language, psychological disorders, dementia, or similar reasons
  • Unable to provide informed consent
  • Known allergy or hypersensitivity to Propofol or Sevoflurane
  • Known or suspected non-compliance, drug or alcohol abuse
  • Participation in another investigational drug study within 30 days before or during this study
  • Previous enrolment in this study
  • Investigator, family members, employees, or dependent persons enrolled

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital Zurich

Zurich, Switzerland, 8091

Actively Recruiting

Loading map...

Research Team

E

Etienne X Keller, Ass Prof, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here